| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
53,543,000 |
| Market
Cap: |
10.88(B) |
| Last
Volume: |
418,372 |
Avg
Vol: |
474,971 |
| 52
Week Range: |
$164.52 - $273.43 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 456 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
7,942 |
11,192 |
| Total Buy Value |
$0 |
$0 |
$1,447,725 |
$2,162,353 |
| Total People Bought |
0 |
0 |
3 |
3 |
| Total Buy Transactions |
0 |
0 |
3 |
5 |
| Total Shares Sold |
1,636 |
25,558 |
49,996 |
92,833 |
| Total Sell Value |
$374,194 |
$6,377,856 |
$11,292,577 |
$21,658,880 |
| Total People Sold |
2 |
6 |
6 |
8 |
| Total Sell Transactions |
2 |
10 |
16 |
28 |
| End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Wallman Richard F |
Director |
• • – |
2016-05-10 |
4 |
OE |
$37.81 |
$453,342 |
D/D |
11,990 |
27,420 |
|
- |
|
| Massaro George |
Director |
• • – |
2016-05-09 |
4 |
AS |
$81.49 |
$80,942 |
D/D |
(985) |
12,135 |
|
- |
|
| Wallman Richard F |
Director |
• • – |
2016-05-06 |
4 |
S |
$81.00 |
$220,320 |
D/D |
(2,720) |
15,430 |
|
- |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2016-05-01 |
4 |
D |
$79.27 |
$18,787 |
D/D |
(237) |
10,554 |
|
- |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2016-04-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
324,928 |
|
- |
|
| Molho Davide |
Corporate Executive VP |
• • – |
2016-04-06 |
4 |
AS |
$80.00 |
$2,453,360 |
D/D |
(30,667) |
59,345 |
|
- |
|
| Molho Davide |
Corporate Executive VP |
• • – |
2016-04-06 |
4 |
OE |
$36.25 |
$1,164,044 |
D/D |
30,667 |
90,012 |
|
- |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2016-03-02 |
4 |
AS |
$75.00 |
$1,505,400 |
D/D |
(20,072) |
383,636 |
|
- |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2016-03-02 |
4 |
OE |
$59.41 |
$1,192,478 |
D/D |
20,072 |
403,708 |
|
- |
|
| Gillett Nancy |
Corporate Executive VP |
• • – |
2016-03-02 |
4 |
S |
$75.78 |
$62,328 |
D/D |
(822) |
11,034 |
|
- |
|
| Gillett Nancy |
Corporate Executive VP |
• • – |
2016-03-02 |
4 |
S |
$74.86 |
$526,125 |
D/D |
(7,015) |
26,711 |
|
- |
|
| Gillett Nancy |
Corporate Executive VP |
• • – |
2016-03-02 |
4 |
OE |
$36.25 |
$683,190 |
D/D |
15,419 |
33,726 |
|
- |
|
| Gillett Nancy |
Corporate Executive VP |
• • – |
2016-03-02 |
4 |
S |
$75.35 |
$383,553 |
D/D |
(5,080) |
11,856 |
|
- |
|
| Gillett Nancy |
Corporate Executive VP |
• • – |
2016-03-02 |
4 |
S |
$75.11 |
$735,213 |
D/D |
(9,775) |
16,936 |
|
- |
|
| Ackerman Thomas F |
Senior Financial Advisor |
• • – |
2016-02-29 |
4 |
D |
$73.70 |
$290,599 |
D/D |
(3,943) |
111,346 |
|
- |
|
| Ackerman Thomas F |
Senior Financial Advisor |
• • – |
2016-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
8,380 |
115,289 |
|
- |
|
| Gillett Nancy |
Corporate Executive VP |
• • – |
2016-02-29 |
4 |
S |
$73.50 |
$267,981 |
D/D |
(3,646) |
18,307 |
|
- |
|
| Crowley John J |
SVP, Chief Accounting Officer |
• • – |
2016-02-28 |
4 |
D |
$73.70 |
$5,601 |
D/D |
(76) |
5,883 |
|
- |
|
| Ackerman Thomas F |
Senior Financial Advisor |
• • – |
2016-02-28 |
4 |
D |
$73.70 |
$38,545 |
D/D |
(523) |
106,909 |
|
- |
|
| Molho Davide |
Corporate Executive VP |
• • – |
2016-02-28 |
4 |
D |
$73.70 |
$48,200 |
D/D |
(654) |
59,345 |
|
- |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2016-02-28 |
4 |
D |
$73.70 |
$176,659 |
D/D |
(2,397) |
383,636 |
|
- |
|
| Johst David P |
Corporate Executive VP |
• • – |
2016-02-28 |
4 |
D |
$73.70 |
$83,576 |
D/D |
(1,134) |
160,746 |
|
- |
|
| Gillett Nancy |
Corporate Executive VP |
• • – |
2016-02-28 |
4 |
D |
$73.70 |
$36,629 |
D/D |
(497) |
21,953 |
|
- |
|
| Crowley John J |
SVP, Chief Accounting Officer |
• • – |
2016-02-27 |
4 |
D |
$73.70 |
$5,012 |
D/D |
(68) |
5,959 |
|
- |
|
| Ackerman Thomas F |
Senior Financial Advisor |
• • – |
2016-02-27 |
4 |
D |
$73.70 |
$96,916 |
D/D |
(1,315) |
107,432 |
|
- |
|
1200 Records found
|
|
Page 39 of 48 |
|
|
3.34 (1.62%) 
